A recent study evaluated the use of an artificial pancreas system by people with type 1 diabetes. The study involved 43 participants, who used the system for six months. The artificial pancreas is an automated system that regulates blood glucose levels by administering insulin or glucagon as needed. The participants experienced significantly fewer episodes of hypoglycemia and hyperglycemia compared to when they self-managed their diabetes. The artificial pancreas also allowed them to achieve more time in target glycemic range. The participants reported a reduction in diabetes-related distress and burden as well as improved quality of life. The authors conclude that the use of an artificial pancreas system could be an effective tool to reduce the disease management burden for people with type 1 diabetes.
Welcome to Our Weekly Magazine
Become the best version of yourself Sign-up for our weekly magazine.
Become the best version of yourself today.
We send a weekly roundup of our best work and highlight standout community members. It's free, and you can always leave if it's not your jam.
Artificial Pancreas and Diabetes Management
See medical disclaimer below.
The ideas expressed here are solely the opinions of the author and are not researched or verified by AGEIST LLC, or anyone associated with AGEIST LLC. This material should not be construed as medical advice or recommendation, it is for informational use only. We encourage all readers to discuss with your qualified practitioners the relevance of the application of any of these ideas to your life. The recommendations contained herein are not intended to diagnose, treat, cure or prevent any disease. You should always consult your physician or other qualified health provider before starting any new treatment or stopping any treatment that has been prescribed for you by your physician or other qualified health provider. Please call your doctor or 911 immediately if you think you may have a medical or psychiatric emergency.